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ABSTRACT
Cancer is ranked as one of the top killers in all
human diseases and continues to have a devastat-
ing effect on the population around the globe.
Current research efforts are aiming to accelerate
our understanding of the molecular basis of cancer
and develop effective means for cancer diagnostics,
treatment and prognosis. An altered pattern of
epigenetic modifications, most importantly DNA
methylation events, plays a critical role in tumor-
igenesis through regulating oncogene activation,
tumor suppressor gene silencing and chromosomal
instability. To study interplay of DNA methylation,
gene expression and cancer, we developed
a publicly accessible database for human DNA
Methylation and Cancer (MethyCancer, http://
methycancer.genomics.org.cn). MethyCancer hosts
both highly integrated data of DNA methylation,
cancer-related gene, mutation and cancer informa-
tion from public resources, and the CpG Island (CGI)
clones derived from our large-scale sequencing.
Interconnections between different data types were
analyzed and presented. Furthermore, a powerful
search tool is developed to provide user-friendly
access to all the data and data connections.
A graphical MethyView shows DNA methylation
in context of genomics and genetics data facilitat-
ing the research in cancer to understand genetic
and epigenetic mechanisms that make dramatic
changes in gene expression of tumor cells.
INTRODUCTION
As the world’s second biggest killer after cardiovascular
disease, cancer causes millions of deaths per year and is
a worldwide threat to human health. Cancer has been
considered as a genetic disease that involves in molecular,
cellular and systematic dysfunction. Thus, the imperative
task in cancer research ﬁeld is to understand the
mechanism of these dysfunctions, thereby facilitate to
develop more eﬀective means for cancer diagnostics,
treatment and prognosis. Currently, there are several
comprehensive projects devoted for such purpose, includ-
ing The Cancer Genome Atlas (TCGA) in US (1) and
Cancer Genome Project (CGP) in UK (http://www.
sanger.ac.uk/genetics/CGP/). China recently initiated the
Cancer Genome/Epigenome Project focusing on certain
types of cancers that have high incidence and mortality
rate in the Chinese population.
Since the discovery of epigenetic modiﬁcation involved
in human cancer in 1983 (2), scientists have been engaged
in dissecting the roles of epigenetic abnormalities in
tumorigenesis. It has been well recognized that both
genetic and epigenetic modiﬁcations function at all
stages of cancer development (3). An altered pattern of
epigenetic modiﬁcations, most importantly DNA methyl-
ation events, plays a critical role in tumorigenesis through
regulating oncogene activation (2,4–7), tumor-suppressor
gene silencing (8–10) and chromosomal instability (11).
Recent technological advances allow cancer epigenetics
to be studied on genomic scale (12). The study of global
methylation patterns of human genome and altered
DNA methylation patterns in tumorigenesis oﬀer great
potential for developing strategies to provide molecular
The authors wish it to be known that, in their opinion, the first four authors should be regarded as joint First Authors.
*To whom correspondence should be addressed. Tel: +86 10 80485492; Fax: +86 10 80498676; Email: wangjing@genomics.org.cn
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.screening for cancer risk, early detection, prevention and
treatment.
Currently there are several resources available for
cancer research, such as the Cancer Genome Anatomy
Project (CGAP) (13), Catalog of Somatic Mutations
in Cancer (COSMIC) (14) and Atlas of Genetics and
Cytogenetics in Oncology and Haematology (AGCOH)
(15), all of which provide useful information regarding the
cancer genetics. For study of DNA methylation, the DNA
Methylation Database (MethDB) is a well-maintained
resource to store DNA methylation data and to make the
data readily available to the public (16). Although the
Human Epigenome Project (HEP) is aiming to identify,
catalog and interpret genome-wide DNA methylation
patterns of all human genes in all major tissues (17,18),
there is no specialized database focusing on the correlation
among DNA methylation, gene expression and cancer
types. On the other hand, as resources of both cancer/
cancer gene and DNA methylation are complementary to
each other, there is a growing need to integrate the data
to provide a comprehensive dataset for convenience of
in-depth data mining. MethyCancer is thus developed to
study the interesting interplay between DNA methylation,
gene expression and cancer through large-scale data
integration, production and mining. Our MethyCancer
contains both highly integrated data from public resources
with manual curation, and experimental data pro-
duced from the Cancer Epigenome Project in China.
As a bridge to study both DNA methylation and cancer,
MethyCancer could function both as an information
resource and analysis platform for study of CGI distribu-
tion in human genes, alteration of DNA methylation
patterns in promoter CGIs, identiﬁcation of novel cancer
genes altered by DNA methylation alone or in combina-
tion with genetic events, and discovery of novel epigenetic
targets.
DATA CONTENT AND DATA INTEGRATION
There are mainly four types of data included in
MethyCancer: (i) CGI clones and global CGI predictions,
(ii) DNA methylation data, (iii) cancer information, genes
and mutations and (iv) correlation among DNA methyla-
tion, gene expression and cancer.
In order to study the global CGI distribution in human
genome and alteration of DNA methylation patterns in
promoter CGIs, we have generated approximately 20 000
CGI clone sequences by large-scale sequencing of the
CGI library from the Sanger Institute (19). The number
continues to increase with development of the new
sequencing technologies. In addition, 17 132 CGI clone
sequences downloaded from UHN Human CpG Island
Microarray Database (20) were also integrated. Taken
together, currently a total of 34 738 CGI clones have been
included in MethyCancer database. By mapping the
clones onto human genome (NCBI Build36) using
BLAT and BLAST, all clones were clustered into 18 240
genomic loci. To verify the experimental CGI sequences
and identify novel candidate CGIs, CGI predictions on
the whole human genome were performed using CpGi130
(21) with criteria of: (i) length greater than 500bp, (ii) GC
content no less than 55%, and (iii) the ratio of observed
CpG frequency over the expected frequency exceeds 0.65
(22). CGI predictions from UCSC (23) are also included
in MethyCancer.
The DNA methylation data were mainly integrated
from MethDB, HEP and Methylation Landscape of
Human Genome at Columbia University (Columbia)
(24). The data from MethDB contains the human DNA
methylation patterns, proﬁles and total methylation
content data for diﬀerent tissues and phenotypes coming
from thousands of experiments. The HEP data were
produced by bisulﬁte DNA sequencing. The data types
include analysis, trace, CpG variation and sample, where
‘analysis’ is a cluster of traces and ‘CpG variation’
refers to the position of the C of each CpG. Data from
Columbia include genome-scale dataset of methylated
domains and unmethylated domains in human brain
tissues. Since the data from diﬀerent resources are
heterogeneous, we ﬁrst created a uniform format to
describe the diverse data and then integrated the data by
mapping the corresponding sequences onto the human
genome. Less than 5% of data without hits on the genome
were discarded. A total of 197 493 sequences (including
CGI clones and predictions) are mapped onto human
genome, and these sequences were further clustered into
64 681 distinct genomic loci, which we termed MethyLoci.
Here we use MethyLoci to represent both CGI and
methylation data for convenience of data explanation
since altered CGI methylation patterns contribute to
tumorigenesis.
The data of cancer classiﬁcation, pathology and
cytogenetics, cancer-related genes, as well as mutations
are mainly from CGAP, the website of National Cancer
Institute (NCI, http://www.cancer.gov/), CGP Cancer
Gene Census (25), COSMIC, AGCOH, OMIM, and
hundreds of paper reviews for the top 10 cancers listed
in WHO, respectively. To identify novel cancer genes,
additional human genes and transcripts from Ensembl
(26) were also integrated. After normalization, non-
redundant gene sets were grouped into three categories
with the estimates of conﬁdence of their relationship with
cancer: (i) annotated cancer gene, (ii) candidate cancer
gene and (iii) other gene. All mutations were mapped
to genes and thus the correlation of cancer types, cancer
genes and mutations are well established.
In order to elucidate the interplay of DNA methylation,
gene expression and cancer types, we annotated
MethyLoci to genes by genomic mapping, and linked
methylation data with cancers via cancer genes. All genes
were further classiﬁed into nine categories based on this
analysis, e.g. annotated/candidate cancer gene with
experimental/predicted methylation data or without
methylation data and other gene with experimental/
predicted methylation data or without methylation data.
Moreover, gene promoters with experimental validation
were extracted from the Eukaryotic Promoter Database
(EPD) (27), which facilitates users to study DNA
methylation, especially methylation patterns in promoter
CGIs, in context of precise gene structures. Gene
expression data from CGAP and UniGene (28) was
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possible changes in gene expression by alteration of
methylation patterns. Accurate correlations between
DNA methylation and expression proﬁles are diﬃcult to
establish. But this will become evident as more DNA
methylation patterns with particular states of gene activity
emerge (29). The inclusion of functional classiﬁcations of
genes by Gene Ontology (GO) (30), proteins, pathways,
mutations and references help users to interpret the data
so as to identify novel cancer genes or select candidate
genes for further experimental conﬁrmation. Genome-
wide repetitive sequences were predicted and included
in MethyCancer for study of CGI distribution and
methylation proﬁling since the genome of the cancer
cell undergoes global hypomethylation at repetitive
sequences (31).
The current version of MethyCancer contains 485
annotated cancer genes, of which 323 are supported
by experimentally validated methylation data and 114
matched with CGI predictions, 6615 candidate cancer
genes, of which 3698 and 1900 are supported by
experimental methylation data and CGI predictions,
respectively and 24 020 other genes. The data statistics
dated 1 August 2007 are shown in Table 1. More detailed
statistical ﬁgures and tables are available on the
MethyCancer website. All data can be downloaded free
of charge from our FTP site (http://methycancer.
genomics.org.cn/FTP.do).
DATABASE USAGE AND ACCESS
MethyCancer provides users a powerful search engine to
query diﬀerent data types and data interactions housed in
the database. Besides the simple keyword search,
MethyCancer oﬀers advanced searches, namely
Methylation Search, Gene Search, Cancer Search, Clone
Search and Repeat Search. Taken the Methylation
Search as an example, users can specify and combine the
query options such as methylation type (pattern, proﬁle,
content, domain), data source (BIG, UHN, MethDB,
HEP, Columbia), experimental method, sample informa-
tion (tissue, sex, age, phenotype) and chromosomal
positions. Gene Search and Cancer Search would be the
recommended starting points to surf MethyCancer, as
users will be more familiar with the corresponding terms.
‘Methy&Cancer’ is a special module dedicated to study
the relationship amongst DNA methylation, gene and
cancer. Users can query the interconnections between the
three data types and study the methylation status of
certain cancer genes in a speciﬁc tissue. For example, if
a user is interested in breast cancer and wants to know
how many breast cancer genes with supportive experi-
mental methylation data from BIG/UHN and HEP, all he
or she needs to do is select two gene categories of
‘Annotated/Candidate cancer genes with experimental
methylation data’ from the pull-down menu, then type
‘breast tumor’ in the search ﬁeld of Cancer Name, and
select BIG/UHN and HEP in Methylation Data Source.
Users may also deﬁne speciﬁc expression tissues and genes
with methylation data in promoter regions. A list of genes
and methylation data will be returned and a factual
detailed report could be shown upon demand.
As an important and eﬃcient visualization tool,
MethyView is developed to facilitate the users to browse
methylation data in the context of existing genome
annotations. MethyView is composed of three layers
of sub-viewers in hierarchical architecture, namely
ChroView, MethyLoci Survey and MethyLoci Detail
View. ChroView contains an outline of a chromosome
including statistics of cancer genes, methylation-related
genes and methylation data. ChroView allows users to
center the map onto a speciﬁc chromosome band to
expand for more detailed views. MethyLoci Survey shows
where the MethyLoci are located in chromosomal regions
and the distribution of its sourcing data (BIG/UHN,
MethDB, HEP, Columbia, CGI predictions). By clicking
on MethyLoci or original methylation data from diﬀerent
resources, users can switch to the MethyLoci Detail
View, which displays the methylation levels in the form of
a matrix. Each color-coded square within the matrix
represents one CpG site and the color coding represents
the diﬀerent methylation level (from yellow to blue, it
represents from 0% to 100% methylation and gray
indicates CpG sites for which methylation levels could
not be determined). Clicking on a square reveals the level
of methylation observed at that particular CpG site. Each
row represents all the CpG sites of one methylation record
shown at the bottom of the MethyLoci Detail View. Rows
of squares are grouped by diﬀerent data sources and
tissues. If one continues to zoom in on the MethyLoci, the
absolute position of each CpG site will be shown. At each
layer of MethyView, gene distribution is plotted and
chromosome coordinates and transcripts are also shown.
By enlarging a speciﬁc gene, the methylation data will be
Table 1. MethyCancer data content and statistics as of 1 August 2007
Data content Data statistics
Methylation
Methylation data 199607
MethyLoci
a 64681
Tissue 145
Sample 15005
Experiment 15658
Cancer and gene
Cancer 511
Cancer-related gene 7100
Annotated cancer gene 485
with methylation data 437
Candidate cancer gene 6615
with methylation data 5598
Other gene 24020
with methylation data 11561
Other integrated data
EPD
b 1794
GO
c 6193
SNP
d 57790
Pathway 502
Repeat 5012310
Reference 27547
aMehyLoci: distinct genomic loci of clustered methylation sequences.
bEPD: Eukaryotic Promoter Database.
cGO: Gene Ontology.
dSNP: Single Nucleotide Polymorphism.
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exons and introns, as well as distribution of repetitive
sequences. A factual report for each element contained
in the visualization system is displayed automatically on
demand. Links to MethyView are also available in various
search result pages.
As shown in Figure 1, all data and tools housed in
MethyCancer are crosslinked, and the whole website
forms an interrelated network, which help users to utilize,
analyze and understand the data more eﬃciently.
SYSTEM DESIGN AND IMPLEMENTATION
MethyCancer was developed using our established pipe-
line for biological database systems (32–35). It consists
of three hardware components: a Word Wide Web
server, a database server and a computational server for
sequence analysis. The system is based on a MySQL
relational database, and the front end consists of a set
of JSP scripts running on an Apache Tomcat web server.
The web services were developed using Apache Struts,
a Java web application framework and Hibernate, a high-
performance object/relational persistence and query
service for Java, both of which help improve the software
quality and ensure the stability of the web services. The
back-end data analysis programs were written by PERL,
which are available upon request. The BLAST and CGI
prediction tool run on clusters of supercomputers.
FUTURE DEVELOPMENT
Aiming to build an integrated research platform for
studying the interplay of DNA methylation, gene expres-
sion and cancer, continued eﬀorts will be made to update
Figure 1. Screenshot showing the interrelation of MethyCancer data and tools. Users access the data through search engine and study the
correlation of DNA methylation, gene expression and cancer types through Methy&Cancer. All data and data connections can be viewed through
MethyView.
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functionality. MethyCancer will also serve as a platform
by which we would like to share data and analytical results
from the Cancer Genome/Epigenome Project in China
with colleagues all over the world. Newly sequenced CGI
clones and data from our CGI array and global DNA
methylation proﬁling study will be added as soon as they
become available. Results from our gene expression
proﬁling project will also be incorporated, and targeted
to predict human transcriptome based on transcript
sampling data. Considering that DNA methylation plays
an important role not only in cancer but also other
diseases and biological processes, such as loss of imprint-
ing and aging, we plan to extend the scope of the diseases,
and include other methylation-related diseases. Since
histone modiﬁcation is also recognized as hallmarks of
gene silencing and involved in tumorigenesis, as more data
generated from histone modiﬁcation study (36), we would
extend the research scope and integrate histone modiﬁca-
tion data into MethyCancer. Finally, we will improve the
current tools for CGI predictions based on our compre-
hensive CGI clone set, and will integrate other tools
for predicting methylation status of CGI and promoters.
We hope our continuous eﬀorts in MethyCancer will
contribute to the improvement of global human health.
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